cristal - cryolipolysis skin contouring system
i-medix pty ltd - 62441 - cryolipolysis skin contouring system - the cristal cryolipolysis is a medical device intended to treat localised fat deposits by applying cooling in a controlled, precise and localised manner into fat cells.
urokinase medac 10,000 iu, powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 10,000 international unit(s) - enzymes; urokinase
urokinase medac 50,000 iu, powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 50,000 international unit(s) - enzymes; urokinase
urokinase medac 100,000 iu, powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 100,000 international unit(s) - enzymes; urokinase
urokinase medac 250,000 iu powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 250,000 international unit(s) - enzymes; urokinase
urokinase medac 500,000 iu, powder for solution for infusion
medac gesellschaft fur klinische spezialpraparate mbh - urokinase - powder for solution for infusion - 500,000 international unit(s) - enzymes; urokinase
thermal skin treatment system gel pad
i-medix pty ltd - 56311 - thermal skin treatment system gel pad - to be applied to the skin of the patient to provide thermal coupling at the interface between the thermal skin treatment system applicator and the treatment site on the patient.
miloxan
merial animal health limited - clostridium perfringens beta toxoid clostridium perfringens epsilon toxoid clostridium septicum toxoid clostridium novyi toxoid clostridium tetani toxoid clostridium sordellii toxoid clostridium chauvoei anaculture - suspension for injection - bovine - immunological - inactivated vaccine
bravoxin 10 inj. susp. s.c.
intervet international b.v. - clostridium perfringens type d (epsilon) toxoid ; clostridium perfringens type c (beta) toxoid >= 18,2 iu/dose; clostridium perfringens type b toxoid >= 18,2 iu/dose; clostridium sordellii toxoïd >= 4,4 u/ml; clostridium perfringens type a (alfa) toxoid >= 0,5 u/ml; clostridium novyi toxoid >= 3,8 iu/ml; clostridium septicum toxoid >= 4,6 elisa u/dose; clostridium chauvoei (inactivated) ; clostridium haemolyticum toxoid >= 17,4 u/ml; tetanus toxoid >= 4,9 elisa u/dose - suspension for injection - clostridium haemolyticum toxoid; clostridium tetani toxoid; clostridium novyi toxoid; clostridium chauvoei; clostridium perfringens; clostridium sordellii toxoid - clostridium - cattle; sheep
covexin 10 inj. susp. s.c.
zoetis belgium sa-nv - clostridium haemolyticum toxoid >= 16,5 u/ml; tetanus toxoid >= 2,5 u/ml; clostridium septicum toxoid >= 3,6 u/ml; clostridium novyi toxoid >= 1,2 u/ml; clostridium perfringens type c (beta) toxoid >= 12,4 u/ml; clostridium perfringens type d (epsilon) toxoid >= 5,1 u/ml; clostridium perfringens type a toxoid >= 0,9 u/ml; clostridium perfringens type b toxoid >= 12,4 u/ml; clostridium chauvoei (inactivated) ; clostridium sordellii toxoïd >= 0,8 u/ml - suspension for injection - clostridium chauvoei-septicum; clostridium haemolyticum toxoid; clostridium novyi toxoid; clostridium perfringens; clostridium tetani toxoid; clostridium sordellii toxoid - clostridium - cattle; sheep